Logo

Siena Biotech Buys More Licenses to GeneGo's MetaCore

Jul 07, 2006
NEW YORK (GenomeWeb News) - GeneGo said today that Siena Biotech has expanded its collection of MetaCore licenses by an undisclosed amount.
 
Siena is using the MetaCore technology to integrate multiple data types including proteomics and chemogenomics information.
 
Financial terms were not disclosed.
 
Other customers have recently extended their licenses with GeneGo, such as NHLBI in June and Merck in January.

Filed under

Informatics
Breaking News
The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.